Correlation Between Rani Therapeutics and Equillium
Can any of the company-specific risk be diversified away by investing in both Rani Therapeutics and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rani Therapeutics and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rani Therapeutics Holdings and Equillium, you can compare the effects of market volatilities on Rani Therapeutics and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rani Therapeutics with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rani Therapeutics and Equillium.
Diversification Opportunities for Rani Therapeutics and Equillium
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Rani and Equillium is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Rani Therapeutics Holdings and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Rani Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rani Therapeutics Holdings are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Rani Therapeutics i.e., Rani Therapeutics and Equillium go up and down completely randomly.
Pair Corralation between Rani Therapeutics and Equillium
Given the investment horizon of 90 days Rani Therapeutics Holdings is expected to under-perform the Equillium. But the stock apears to be less risky and, when comparing its historical volatility, Rani Therapeutics Holdings is 1.49 times less risky than Equillium. The stock trades about -0.47 of its potential returns per unit of risk. The Equillium is currently generating about -0.16 of returns per unit of risk over similar time horizon. If you would invest 85.00 in Equillium on September 13, 2024 and sell it today you would lose (15.00) from holding Equillium or give up 17.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Rani Therapeutics Holdings vs. Equillium
Performance |
| Timeline |
| Rani Therapeutics |
| Equillium |
Rani Therapeutics and Equillium Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rani Therapeutics and Equillium
The main advantage of trading using opposite Rani Therapeutics and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rani Therapeutics position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.| Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |